Inhibitory potency of R-region specific antisense oligonucleotides against in vitro DNA polymerization and template-switching reactions catalysed by HIV-1 reverse transcriptase

International Journal of Biochemistry and Cell Biology

Volumn 29, Issue 11, 1997, Pages 1285-1295

  Borkow, Gadi ^a   Arion, Dominique ^a   Noronha, Anne ^b   Scartozzi, Margherita ^b   Damha, Masad J ^b   Parniak, Michael A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Antisense oligonucleotides; HIV 1; Inhibition; Reverse transcriptase; Strand transfer template switching

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; RNA HYBRIDIZATION; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

BIOPOLYMERS; CATALYSIS; DNA; GENOME, VIRAL; HIV-1 REVERSE TRANSCRIPTASE; MOLECULAR STRUCTURE; OLIGONUCLEOTIDES, ANTISENSE; REPETITIVE SEQUENCES, NUCLEIC ACID; TEMPLATES, GENETIC;

ARA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031467958     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(97)00067-8     Document Type: Article

References (38)

1. Anazodo M. I., Salomon H., Friesen A. D., Wainherg M. A. and Wright J. A. (1995) Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome. Gene 166, 227-232.
2. Lys3. Biochem. Biophys. Res. Commun. 225, 839-843.
3. lys-3 as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/ template-switching reaction. J. Biol. Chem. 269, 14672-14680.
4. Ben-Artizi H., Zeelon E., Amit B., Wortzel A., Gorecki M. and Panet A. (1993) RNase H activity of reverse transcriptases on substrates derived from the 5' end of retroviral genome. J. Biol. Chem. 268, 16465-16471.
5. Biasolo M. A., Radaelli A., Del Pup L., Franchin E., Giuli-Morghen C. and Palu G. (1996) A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1. J. Virol. 70, 2154-2161.
6. Bordier B., Helene C., Barr P. J., Litvak S. and Sarih-Cottin L. (1992) In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription. Nucleic Acids Res. 20, 5999-6006.
7. Bordier B., Perala-Heape M., Degols G., Lebleu B., Litvak S., Sarih-Cottin L. and Helene C. (1995) Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells. Proc. Natl Acad. Sci. U.S.A. 92, 9383-9387.
8. Borkow G., Fletcher R. S., Barnard J., Arion D., Motakis D., Dimitrienko G. I. and Parniak M. A. (1997) Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tertbutylbenzoyl)-2-hydroxy-1 -naphthaldehyde hydrazone. Biochemistry 36, 3179-3185.
9. Cohen J. S., ed. (1989) Oligonucleotides: Antisense Inhibitors of Gene Expression. CRC Press, Boca Raton, FL.
10. Cook P. D. (1991) Medicinal chemistry of antisense oligonucleotides - future opportunities. Anti-Cancer Drug Design 6, 585-607.
11. Crooke S. T. (1992) Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol Toxicol. 32, 329-376.
12. Damha M. J., Giannaris P. A. and Zabarylo S. V. (1990) An improved procedure for derivatization of controlled-pore glass beads for solid-phase oligonucleotide synthesis. Nucleic Acids Res. 18, 813-3821.
13. Damha M. J. and Ogilvie K. K. (1993) Oligonucleotide synthesis. In Protocols for Oligonucleotides and Analogs: Synthesis and Properties, Methods in Molecular Biology (Edited by Agrawal S.), pp. 1-114. The Humana Press, Totowas, NJ.
14. Damha M. J., Giannaris P. A. and Marley P. (1994) Antisense L/D-oligonucleotide chimeras: nuclease stability, base-pairing properties, and activity at directing RNase H. Biochemistry 33, 7877-7885.
15. De Clercq E. (1993) HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase. Med. Res. Rev. 13, 229-258.
16. Demirhan I., Hasselmayer O., Hofmann D., Chandra A., Svinarchuk F. P., Vlassov V. V., Engels J. and Chandra P. (1994) Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-l)-LTR by antisense oligonucleotides. Virus Genes 9, 113-119.
17. Fletcher R. S., Syed K., Mithani S., Dmitrienko G. I. and Parniak M. A. (1995) Carboxanilide derivative nonnucleoside inhibitors of HIV-1 reverse transcriptase interact with different mechanistic forms of the enzyme. Biochemistry 34, 4036-4042.
18. Fletcher R. S., Holleschak G., Nagy E., Arion D., Borkow G., Gu Z., Wainberg M. A. and Parniak M. A. (1996) Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase. Prot. Exp. Purif. 7, 27-32.
19. Gait M. J. (1984) Oligonucleotide Synthesis: A Practical Approach. IRL Press, Oxford.
20. Giannaris P. A. and Damha M. J. (1993) Hybridization properties of oligoarabinonucleosides. Can. J. Chem. 72, 909-917.
21. Giannaris P. A. and Damha M. J. (1994) Oligoribonucleotides containing 2',5'-phosphodiester linkages exhibit binding selectivity for 3',5'-RNA versus 3',5'-ssDNA. Nucleic Acids Res. 21, 4742-4749.
22. Goff S. (1990) Retroviral reverse transcriptase: synthesis, structure, and function. J. AIDS 3, 817-819.
23. Gu Z., Fletcher R. S., Arts E. J., Wainberg M. A. and Parniak M. A. (1994) The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2',3'-dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro. J. Biol. Chem. 269, 28118-28122.
24. Jones R. J., Lin K. Y., Milligan J. F., Wadwani S. and Matteucci M. D. (1993) Synthesis and binding properties of pyrimidine oligodeoxynucleoside analogues containing neutral phosphodiester replacements: the formacetal and 3'-thioaceltal internucleoside linkages. J. Org. Chem. 58, 2983-2991.
25. Kellam P., Boucher C. A. B. and Larder B. A. (1992) Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine. Proc. Natl Acad. Sci. U.S.A. 89, 1934-1938.
26. Larder B. A. and Kemp S. D. (1989) Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246, 1155-1158.
27. Meng B., Kawai S. H., Wang D., Just G., Gianarris P. A. and Damha M. J. (1993) A sulfide-linked oligonucleotide analogue with selective hybridization properties. Angew Chem. Int. Engl. 32, 729-731.
28. Merluzzi V. J., Hargrave K. D., Labadia M., Grozinger K., Skoog M. T., Wu J. C., Shih C.-K., Eckner K., Hattox S., Adams J., Rosehthal A. S., Faanes R., Eckner R. J., Koup R. A. and Sullivan J. L. (1990) Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science 250, 1141-1413.
29. Mitsuya H., Yarchoan R. and Broder S. (1990) Molecular targets for AIDS therapy. Science 249, 1533-1544.
30. Mohan P. (1992) Anti-AIDS drug development: challenges and strategies. Pharmaceut. Res. 9, 703-714.
31. Puglisi J. D. and Tinoco I. (1989) Absorbance melting curves of RNA. Meth. Enzymol. 180, 304-325.
32. Quaedflieg P. J. L. M., Van der Marcel G. A., Kuyl-Yenheskiely E. and Van Boom J. H. (1991) Synthesis of (3'-5') methylene acetal-linked dinucleosides containing cytosine bases. Recl. Trav. Chim. Pays-Bas 110, 435-436.
33. Reynolds R. C., Crooks P. A., Maddry J. A., Aktar M. S., Montogomery J. A. and Secrist J. A. (1992) Synthesis of thymidine dimers containing internuclcoside sulfonate and sulfonamide linkages. J. Org. Chem 57, 2983-2985.
34. Richman D. D. (1993) HIV drug resìstance. Annu. Rev. Pharmacol. Toxicol. 33, 149-164.
35. Sczakiel G., Pawlita M. and Kleinheinz A. (1990) Specific inhibition of human immunodeficiency virus type 1 replication by RNA transcribed in sense and antisense orientation from the 5'-leader/gag region. Biochem Biophys. Res. Commun. 169, 643-651.
36. Uhlmann E. and Peyman A. (1990) Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 90, 543-584.
37. Vasseur J.-J., Debart F., Sanghvi Y. S. and Cook P. D. (1992) Oligonucleosides: synthesis of a novel methyl-hydroxylamine-linked nucleoside dimer and its incorporation into antisense sequences. J. Am. Chem. Soc. 114, 4006.
38. Volkmann S., Dannull J. and Moeling K. (1993) The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides. Biochimie 75, 71-78.